Lemaitre Vascular Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $262.4M+19.4% YoYTTM through 30 Jun 2026
Net Income $65.7M+49.1% YoYTTM through 30 Jun 2026
Free Cash Flow $73.8MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 72.7% |
| EBITDA Margin | 33.5% |
| Operating Margin | 26.7% |
| Net Margin | 25.0% |
Returns
15.6%ROE
10.3%ROA
11.7%ROIC
Balance Sheet Health
Debt / Equity0.42x
Current Ratio16.31x
Net Debt-$198.4Mnet cash position
Cash & Equivalents$26.6M
Quality Metrics
Altman Z-Score7.16
Piotroski F-Score7 / 9
FCF Margin28.1%
Rule of 4033.5
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $249.6M
Diluted EPS$2.86TTMFY2025: $2.52
Dividend
$0.50Per share, FY20260.62%Yield+2.6%5-yr growth
Capital Allocation
R&D Spend$15.4M
Capex Intensity3.5%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Artegraft | +36.0% |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.